Journalism 101: Exergen Corporation v. Wal-Mart Stores, Inc.
Attached below is an article by Ronald J. Schutz, Esq., that I think you’ll find interesting.
About Me
Warren D. Woessner
Pages
Archives
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
Categories
- 102 Patentability (1)
- About SLW (4)
- Assignment/Ownership (2)
- Claim Construction (1)
- Conferences and Classes (13)
- Doctrine of Equivalents (3)
- Double Patenting (2)
- EP and UK Practice (8)
- Federal Court (8)
- Follow-On Biologics (1)
- Govt Policy/PTO Policy (1)
- Hatch-Waxman (4)
- Inequitable Conduct/Rule 56 (8)
- Infringement (3)
- Int'l Practice and Policy (2)
- Inventorship (1)
- Litigation Issues (5)
- Miscellaneous (2)
- Non-U.S. Practice (21)
- Obviousness (15)
- Opinion Practice (1)
- Organization/Business News (4)
- Patent Reform Legislation (17)
- Patentable Subject Matter (42)
- Patenting Methods/Processes (8)
- People (4)
- Post-Grant Issues (5)
- Prior Art (6)
- Prosecution History Estopped (2)
- Stem Cells/Cloning (15)
- Tech Transfer (7)
- USPTO Practice and Policy (30)
- Utility/How-To-Use (2)
- Written Description Requirements (WDR) (14)
© 2012 Schwegman, Lundberg & Woessner, P.A. All Rights Reserved.
BioTechnology Law Blog
Entries (RSS)
and Comments (RSS).